Foley Partner Judith Waltz authored an article that appeared in the August 2010 edition of Medical Device and Diagnostic Industry titled “U.S. Focuses Enforcement on Manufacturers.” Waltz discusses increasing healthcare enforcement activity under the Obama administration, stating that the federal government has focused enforcement activity on how providers are billing products to government healthcare programs. She recommends that manufacturers review recent False Claims Act settlements and consider whether further scrutiny of their product support services and pricing strategies may be warranted.
Click here to read the complete article.
Author(s)
Related Insights
23 December 2024
Labor & Employment Law Perspectives
Regulating Artificial Intelligence in Employment Decision-Making: What’s on the Horizon for 2025
Share on TwitterShare by EmailShareBack to topEmployment law in 2024 could aptly be summarized as the “Year of Artificial Intelligence Legislation.
23 December 2024
Injunction Stayed: Corporate Transparency Act Enforcement Resumes
The U.S. Department of Justice scored a victory in ongoing litigation over the constitutionality of the Corporate Transparency Act (CTA) when the Fifth Circuit Court of Appeals stayed the nationwide preliminary injunction issued earlier this month by a federal district court in Texas.
23 December 2024
Health Care Law Today
Medicare Telehealth Flexibilities Get a Three-Month Lifeline
Share on TwitterShare by EmailShareBack to topAfter much uncertainty, Congress has extended many Medicare telehealth flexibilities through March 31, 2025, in its end-of-year appropriations bill.